GCM
TMCI icon

Graham Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Graham Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,007
Closed -$27K – 1511
2025
Q4 		$27K Buy
+11,007
New +$47.8K ﹤0.01% 1183
2025
Q3 		– Sell
-15,748
Closed -$92.6K – 1644
2025
Q2 		$92.6K Buy
+15,748
New +$103K ﹤0.01% 1211
2024
Q4 		– Sell
-10,336
Closed -$59.9K – 1478
2024
Q3 		$59.9K Buy
+10,336
New +$66.4K ﹤0.01% 1037
2023
Q2 		– Sell
-8,400
Closed -$212K – 1298
2023
Q1 		$212K Buy
+8,400
New +$197K 0.01% 954

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Graham Capital Management's TMCI Position: Q1 2026 in Review

Graham Capital Management sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 11,007 shares — an estimated $27K sold.

Graham Capital Management first reported a position in TMCI in Q1 2023 and held it in 4 quarters. The position peaked at $212K in Q1 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Graham Capital Management reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 11,007 Treace Medical Concepts shares in Q1 2026, an estimated $27K.
  • Graham Capital Management first reported a position in Treace Medical Concepts in Q1 2023 and held it in 4 quarters.
  • Graham Capital Management's Treace Medical Concepts position peaked at $212K in Q1 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.